CClinicalTrials.gg
Not yet recruitingNCT06515769TG-ARUpdated Jul 23, 2024

Use of Thermography for the Prevention and Diagnosis of Rheumatic Foot

An observational study in Rheumatoid Arthritis, Rheumatoid Arthritis RA and Rheumatic Diseases, sponsored by University of Seville. Not yet recruiting at 1 site in Spain. Open to participants aged 40 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by University of Seville · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
200
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The aim of this observational study is to establish normal thermographic parameters in patients with rheumatoid arthritis, in order to prevent and diagnose rheumatic foot using thermography. The main question to be answered is: What are the normal thermographic parameters in rheumatic foot?

If there is a comparison group: the researchers will compare the thermography of the foot in healthy subjects and in subjects with rheumatoid arthritis to see if there are any alterations in the thermographic image.

Patients who wish to participate in the study will undergo a thermographic study of the foot, which does not entail any risk to their health.

02

Conditions studied

  • Rheumatoid Arthritis
  • Rheumatoid Arthritis RA
  • Rheumatic Diseases

Keywords

  • Rheumatic foot
  • Rheumatoid Arthritis
  • Rheumatic diseases
  • Thermoghrapy
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 318 are open to participants now.

This study's planned enrollment of 200 is above the median of 155 across 1,057 observational studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

University of Seville is the lead sponsor of 127 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Selected patients will be healthy subjects and subjects with more than 5 years of rheumatoid arthritis who wish to voluntarily participate in the study.

Inclusion criteria

  • Patients with rheumatoid arthritis of more than 5 years\' duration
  • Healthy patients without diagnosed systemic disease
  • Patients between 40 and 80 years of age

Exclusion criteria

Exclusion Criteria:

  • Patients who are pregnant or may become pregnant
  • Patients with degenerative diseases or significant cognitive impairment
  • Patients with rheumatic diseases without a diagnosis of rheumatoid arthritis
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Control group: healthy subjects

    Subjects without rheumatoid arthritis or symptoms compatible with this disease

    Diagnostic Test: TERMOGRAPHY

  • Case group: subjects with rheumatoid arthritis

    Subjects diagnosed with rheumatoid arthritis

    Diagnostic Test: TERMOGRAPHY

Interventions

  • Diagnostic testTERMOGRAPHY

    Obtaining an image of the foot using a thermographic camera

06

What researchers measure

Primary outcomes

  1. NORMAL PARAMETERS IN THERMOGRAPHY IN PATIENS WITH HEALTHY FOOT

    Normal parameters of the healthy foot in thermography

    Time frame: One measurement will be taken at the start of the study and another measurement the following 6 month.

Secondary outcomes

  1. NORMAL PARAMETERS IN TERMOGRAPHY IN PATIENS WITH RHEUMATIC FOOT

    Normal parameters in thermography in patients with rheumatic foot

    Time frame: One measurement will be taken at the start of the study and another measurement the following 6 month

07

Study locations

1 site
  • University of Seville
    Seville, 41008, Spain
    • RAQUEL GARCIA DE LA PEÑA DOCTOR, DOCTOR IN HEALTH SCIENCE · Contact · raquelgp@us.es · 954-486-5300
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06515769
Lead sponsor
University of Seville
Responsible party
ANA MARIA RAYO PEREZ (Principal Investigator, University of Seville) — Principal investigator
First posted
Jul 23, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Jan 1, 2025 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
Jul 23, 2024

Study contacts

DOCTOR RAQUEL GARCIA DE LA PEÑA RAQUEL, DOCTOR IN HEALTH SCIENCE
Contact
raquelgp@us.es
9544865300 ext. +34
RAQUEL GARCIA DE LA PEÑA, DOCTOR IN HEALTH SCIENCE
Contact
raquelgp@us.es
9544865300 ext. +34

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion